Medical System Network (4350) Fundamentals 2026 — P/E 13.4x, Revenue Analysis | SniperIQ
Medical System Network (4350) is a JP-listed Healthcare company in Medical - Pharmaceuticals with a market capitalization of ¥14.3B, trading at ¥490.00 on the JPX. This SniperIQ fundamentals page covers Medical System Network's valuation (P/E 13.4x, P/B 0.8x), profitability (net margin 0.8%), revenue (¥132.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Medical System Network's market cap?
Medical System Network (4350) has a market capitalization of approximately ¥14.3B, trading at ¥490.00 on the JPX. Market cap moves with the live share price.
What is Medical System Network's P/E ratio?
Medical System Network's trailing twelve-month P/E ratio is 13.4x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Medical System Network?
Medical System Network runs a net profit margin of 0.8%, a gross margin of 40.7%, and an operating margin of 2.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Medical System Network generate?
Medical System Network reported revenue of ¥132.2B for fiscal year 2025, with net income of ¥1.1B and earnings per share (EPS) of 36.61. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Medical System Network pay a dividend?
Medical System Network offers a trailing dividend yield of about 2.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Medical System Network financially healthy?
Medical System Network carries a debt-to-equity ratio of 2.18x and a current ratio of 0.92x, with a market beta of 0.52. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Medical System Network a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Medical System Network (4350) the key facts are: market cap ¥14.3B, P/E 13.4x, revenue ¥132.2B, 52-week range 433-558. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Medical System Network's full fundamentals live
Get Medical System Network's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.